These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

464 related items for PubMed ID: 16154302

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Modulation of drug release kinetics from hydroxypropyl methyl cellulose matrix tablets using polyvinyl pyrrolidone.
    Hardy IJ, Windberg-Baarup A, Neri C, Byway PV, Booth SW, Fitzpatrick S.
    Int J Pharm; 2007 Jun 07; 337(1-2):246-53. PubMed ID: 17306477
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Release of theophylline and carbamazepine from matrix tablets--consequences of HPMC chemical heterogeneity.
    Viridén A, Abrahmsén-Alami S, Wittgren B, Larsson A.
    Eur J Pharm Biopharm; 2011 Aug 07; 78(3):470-9. PubMed ID: 21316446
    [Abstract] [Full Text] [Related]

  • 8. Comparative evaluation of plastic, hydrophobic and hydrophilic polymers as matrices for controlled-release drug delivery.
    Reza MS, Quadir MA, Haider SS.
    J Pharm Pharm Sci; 2003 Aug 07; 6(2):282-91. PubMed ID: 12935440
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Sustained release dosage forms dissolution behavior prediction: a study of matrix tablets using NIR spectroscopy.
    Tabasi SH, Moolchandani V, Fahmy R, Hoag SW.
    Int J Pharm; 2009 Dec 01; 382(1-2):1-6. PubMed ID: 19660535
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Formulation, release characteristics and bioavailability of novel monolithic hydroxypropylmethylcellulose matrix tablets containing acetaminophen.
    Cao QR, Choi YW, Cui JH, Lee BJ.
    J Control Release; 2005 Nov 28; 108(2-3):351-61. PubMed ID: 16154656
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Influence of poloxamers on the dissolution performance and stability of controlled-release formulations containing Precirol ATO 5.
    Jannin V, Pochard E, Chambin O.
    Int J Pharm; 2006 Feb 17; 309(1-2):6-15. PubMed ID: 16376034
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.